Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1999
06/24/1999CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
06/24/1999CA2315785A1 Peptides and nucleic acids derived from eisenia foetida and the use thereof
06/24/1999CA2315527A1 Human phosphatases
06/24/1999CA2315295A1 110 human secreted proteins
06/24/1999CA2315275A1 P53 regulatory protein called rb18a and uses thereof
06/24/1999CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
06/24/1999CA2315263A1 Reagents and methods useful for detecting diseases of the pancreas
06/24/1999CA2315251A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
06/24/1999CA2315247A1 Mammalian calcitonin-like polypeptide-1
06/24/1999CA2314884A1 Human tumor necrosis factor-r2-like proteins
06/24/1999CA2314407A1 Immunoglobulin-rich milk, production and use thereof
06/24/1999CA2314379A1 Human dendriac and brainiac-3
06/24/1999CA2314342A1 .beta.(1-3)-glucan diagnostic assays
06/24/1999CA2314319A1 Novel surface protein of neisseria meningitidis
06/24/1999CA2314141A1 Glucose regulated gene
06/24/1999CA2313448A1 Ubiquitin-like conjugating protein
06/24/1999CA2313391A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means
06/24/1999CA2311572A1 Extended cdnas for secreted proteins
06/24/1999CA2228730A1 Styelins
06/23/1999EP0924297A1 Sialoadhesin family member-2 (saf-2)
06/23/1999EP0924295A2 DNA encoding neospora dihydrofolate reductase-thymidylate synthase
06/23/1999EP0923941A2 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
06/23/1999EP0923740A2 Methods and compositions for the detection of cervical cancer
06/23/1999EP0923738A1 Methods and compositions for the use of apurinic/apyrimidinic endonucleases
06/23/1999EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
06/23/1999EP0923608A1 Endoglucanases
06/23/1999EP0923607A1 Method for producing polyclonal and monoclonal antibodies
06/23/1999EP0923602A1 Immunocontraceptive compositions containing sperm antigens, and methods of use
06/23/1999EP0690876B1 Protein kinases
06/23/1999EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor
06/23/1999EP0605522B1 Methods for the production of humanized antibodies
06/23/1999EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
06/23/1999EP0496818B1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR
06/23/1999CN1220701A Lipid kinase
06/23/1999CN1220699A Antibodies against interferon alpha/beta receptor
06/23/1999CN1220270A Improved process for stabilizing proteins
06/22/1999US5914392 Anticarcinogenic/antitumor/antimetastasis/antiarthritic agents; wound healing agents; diagnosis
06/22/1999US5914318 Transgenic plants expressing lepidopteran-active δ-endotoxins
06/22/1999US5914260 Fish pancreatic disease virus
06/22/1999US5914251 Nucleic acid molecules encoding placental-derived growth factors
06/22/1999US5914237 Kinase receptor activation assay
06/22/1999US5914234 Methods of detecting growth differentiation factor-11
06/22/1999US5914127 Isolation and uses of caveolae
06/22/1999US5914114 Concensus peptide and amino acid sequences thereof; conjugated to a molecule that increases antigenicity; immunizing mammals against varying strains of enterotoxigenic escherichia coli; colonization factor antigens (cfa)
06/22/1999US5914112 Anti-CD18 antibodies in stroke
06/22/1999US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin
06/22/1999US5914110 Contacting biological fluid sample of the patient suffering from excess immunoglobulins e production in a human with monoclonal antibody or fusion protein and detecting the presence or absence of complex of antibody and interleukin-4
06/22/1999US5914109 Heterohybridomas producing human monoclonal antibodies to HIV-1
06/22/1999US5914095 Polychelants containg amide bonds
06/20/1999CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease
06/20/1999CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases
06/17/1999WO1999029906A2 Gene family with transformation modulating activity
06/17/1999WO1999029888A1 Humanization of murine antibody
06/17/1999WO1999029879A1 VEGETABLE GntI SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY
06/17/1999WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999WO1999029873A1 Cyclic gmp phosphodiesterase
06/17/1999WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999WO1999029863A1 Human interferon-epsilon: a type i interferon
06/17/1999WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029859A1 Gene associated with neoplastic disease or malignancy associated gene
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029849A1 G-protein coupled receptors associated with immune response
06/17/1999WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999WO1999029841A1 Purification and microsequencing of hyaluronidase isozymes
06/17/1999WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
06/17/1999WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999WO1999029720A2 Mammalian alpha helical protein-1
06/17/1999WO1999029718A2 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999WO1999029345A1 Inhibition of tumor growth by macrophage intervention
06/17/1999WO1999029344A1 Product and process for targeting an immune response
06/17/1999WO1999019358A3 Antibody against baculoviruses
06/17/1999WO1999018131A3 ANTI-BiP-ANTIBODIES IN RHEUMATOID ARTHRITIS, METHOD AND TEST KITS FOR DETECTING THEM
06/17/1999WO1999017801A3 Materials and methods relating to the stimulation of cells
06/17/1999WO1999017796A3 Modulation of lerk-2-mediated cell adhesion
06/17/1999WO1999016887A3 Compositions and methods for identifying pkb kinase inhibitors
06/17/1999WO1999015549A3 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
06/17/1999WO1999015541A3 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside
06/17/1999WO1999015539A3 Pentopyranosyl nucleoside, and production and use of the same
06/17/1999WO1999015198A3 Agents for combating bacterial meningitis
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1999008109A9 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
06/17/1999WO1999004237A3 Diagnosis of spongiform encephalopathies using prionins
06/17/1999CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313464A1 Mammalian alpha helical protein-1
06/17/1999CA2313451A1 Cyclic gmp phosphodiesterase
06/17/1999CA2313450A1 G-protein coupled receptors associated with immune response
06/17/1999CA2313381A1 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2312734A1 Vegetable gnti sequences and the use thereof to obtain plants with a reduced or lack of n-acetylglucosaminyltransferase i (gnti) activity
06/17/1999CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system